Department of General Surgery, Henry Ford Hospital, Detroit, MI, USA.
HPB (Oxford). 2011 Oct;13(10):738-44. doi: 10.1111/j.1477-2574.2011.00369.x.
Published data on splenic preservation during distal pancreatectomy have been inconsistent. We hypothesized that patients undergoing spleen-preserving distal pancreatectomy (SPDP) would have fewer infectious and non-infectious complications than those undergoing en bloc distal pancreatectomy with splenectomy (DPS), and that their haematological parameters would be consistent with splenic function.
Of 97 patients who underwent either SPDP using the Warshaw technique or en bloc DPS, 78 met our study inclusion criteria. Records were reviewed for data on age, gender, resection, indications for resection, operative time, blood loss, transfusion requirements, hospital stay, infectious complications, any other complications, postoperative white blood cell (WBC) and platelet counts. Data were analysed using the chi-squared test, the two-sided Mann-Whitney-Wilcoxon text, and simple and multiple logistic regression analyses. A P-value of <0.05 was considered significant.
Patients undergoing SPDP had a shorter length of stay and shorter operative time, were more likely to be completed laparoscopically, less likely to require re-operation, and had fewer infectious and non-infectious complications. However, these differences were not statistically significant. In multiple logistic regression analyses, patient age and length of hospital stay were both significant predictors of the occurrence of non-infectious complications (P= 0.04 and P= 0.006, respectively). Blood transfusion was a significant predictor of postoperative morbidity (P= 0.013 for infectious complications; P= 0.018 for non-infectious complications). White blood cell count was a statistically significant predictor of infectious (P= 0.02) and non-infectious (P= 0.04) complications, whereas platelet count was not. Patients who underwent DPS had statistically significantly higher WBC and platelet counts immediately postoperatively and at 6 months compared with SPDP patients. Postoperative mortality in both the SPDP and DPS groups was 0%. None of the 30 SPDP patients had evidence of splenic infarction. Pancreatic leaks occurred in 18% of patients in the SPDP group, compared with 8% in the DPS group (P < 0.05).
Spleen-preserving distal pancreatectomy using the Warshaw technique is associated with lower postoperative morbidity than DPS. Lower WBC and platelet counts suggest better splenic function in SPDP patients.
关于保脾胰体尾切除术的发表数据一直存在不一致。我们假设与行整块胰体尾切除术联合脾切除术(DPS)的患者相比,行保脾胰体尾切除术(SPDP)的患者的感染性和非感染性并发症更少,且他们的血液学参数与脾功能一致。
97 例行 Warshaw 技术 SPDP 或整块 DPS 的患者中,78 例符合我们的研究纳入标准。回顾记录以获取年龄、性别、切除术、切除术指征、手术时间、失血量、输血需求、住院时间、感染性并发症、其他任何并发症、术后白细胞(WBC)和血小板计数的数据。使用卡方检验、双侧曼-惠特尼-威尔科克森检验以及简单和多元逻辑回归分析进行数据分析。P 值<0.05 认为有统计学意义。
SPDP 组患者的住院时间和手术时间更短,更有可能完成腹腔镜手术,不太可能需要再次手术,且感染性和非感染性并发症更少。然而,这些差异无统计学意义。多元逻辑回归分析中,患者年龄和住院时间是发生非感染性并发症的显著预测因素(P=0.04 和 P=0.006)。输血是术后发病率的显著预测因素(感染性并发症 P=0.013;非感染性并发症 P=0.018)。WBC 计数是感染性(P=0.02)和非感染性(P=0.04)并发症的统计学显著预测因素,而血小板计数则不是。与 SPDP 患者相比,行 DPS 的患者术后即刻和术后 6 个月的 WBC 和血小板计数明显更高。SPDP 和 DPS 两组的术后死亡率均为 0%。30 例 SPDP 患者中无一例有脾梗死证据。SPDP 组患者的胰漏发生率为 18%,而 DPS 组为 8%(P<0.05)。
采用 Warshaw 技术的保脾胰体尾切除术与 DPS 相比,术后发病率更低。较低的 WBC 和血小板计数表明 SPDP 患者的脾功能更好。